Bafna Pharmaceuticals widens net loss to Rs 2.08 crore in Q4

01 Jun 2012 Evaluate

Bafna Pharmaceuticals has reported a widening of its standalone net loss to Rs 2.08 crore for the quarter ended March 31, 2012 as compared to a net loss of Rs 0.85 crore over the same period previous fiscal. However, the net sales of the company increased by 10.57% to Rs 32.73 crore in the quarter under review from Rs 29.60 crore in same period year ago.

For the full year, the company’s net profit declined by 38.05% at Rs 20.74 crore against Rs 33.48 crore for the previous fiscal however, net sales of the company rose 19.43% to Rs 120.98 crore for FY12 from Rs 101.30 crore for FY11.

Bafna Pharma Share Price

149.40 -3.00 (-1.97%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×